Alain Coletta
Université libre de Bruxelles
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Alain Coletta.
IEEE/ACM Transactions on Computational Biology and Bioinformatics | 2012
Cosmin Lazar; Jonatan Taminau; Stijn Meganck; D. Steenhoff; Alain Coletta; Colin Molter; V. de Schaetzen; Robin Duque; Hugues Bersini; Ann Nowé
A plenitude of feature selection (FS) methods is available in the literature, most of them rising as a need to analyze data of very high dimension, usually hundreds or thousands of variables. Such data sets are now available in various application areas like combinatorial chemistry, text mining, multivariate imaging, or bioinformatics. As a general accepted rule, these methods are grouped in filters, wrappers, and embedded methods. More recently, a new group of methods has been added in the general framework of FS: ensemble techniques. The focus in this survey is on filter feature selection methods for informative feature discovery in gene expression microarray (GEM) analysis, which is also known as differentially expressed genes (DEGs) discovery, gene prioritization, or biomarker discovery. We present them in a unified framework, using standardized notations in order to reveal their technical details and to highlight their common characteristics as well as their particularities.
BMC Systems Biology | 2010
Alain Coletta; John W. Pinney; David Weiss Solís; James Marsh; Steve Pettifer; Teresa K. Attwood
BackgroundRegions of protein sequences with biased amino acid composition (so-called Low-Complexity Regions (LCRs)) are abundant in the protein universe. A number of studies have revealed that i) these regions show significant divergence across protein families; ii) the genetic mechanisms from which they arise lends them remarkable degrees of compositional plasticity. They have therefore proved difficult to compare using conventional sequence analysis techniques, and functions remain to be elucidated for most of them. Here we undertake a systematic investigation of LCRs in order to explore their possible functional significance, placed in the particular context of Protein-Protein Interaction (PPI) networks and Gene Ontology (GO)-term analysis.ResultsIn keeping with previous results, we found that LCR-containing proteins tend to have more binding partners across different PPI networks than proteins that have no LCRs. More specifically, our study suggests i) that LCRs are preferentially positioned towards the protein sequence extremities and, in contrast with centrally-located LCRs, such terminal LCRs show a correlation between their lengths and degrees of connectivity, and ii) that centrally-located LCRs are enriched with transcription-related GO terms, while terminal LCRs are enriched with translation and stress response-related terms.ConclusionsOur results suggest not only that LCRs may be involved in flexible binding associated with specific functions, but also that their positions within a sequence may be important in determining both their binding properties and their biological roles.
Database | 2012
Teresa K. Attwood; Alain Coletta; Gareth Muirhead; Athanasia Pavlopoulou; Peter B. Philippou; Ivan Popov; Carlos Romá-Mateo; Athina Theodosiou; Alex L. Mitchell
The PRINTS database, now in its 21st year, houses a collection of diagnostic protein family ‘fingerprints’. Fingerprints are groups of conserved motifs, evident in multiple sequence alignments, whose unique inter-relationships provide distinctive signatures for particular protein families and structural/functional domains. As such, they may be used to assign uncharacterized sequences to known families, and hence to infer tentative functional, structural and/or evolutionary relationships. The February 2012 release (version 42.0) includes 2156 fingerprints, encoding 12 444 individual motifs, covering a range of globular and membrane proteins, modular polypeptides and so on. Here, we report the current status of the database, and introduce a number of recent developments that help both to render a variety of our annotation and analysis tools easier to use and to make them more widely available. Database URL: www.bioinf.manchester.ac.uk/dbbrowser/PRINTS/
BMC Bioinformatics | 2012
Jonatan Taminau; Stijn Meganck; Cosmin Lazar; David Steenhoff; Alain Coletta; Colin Molter; Robin Duque; Virginie de Schaetzen; David Weiss Solís; Hugues Bersini; Ann Nowé
BackgroundWith an abundant amount of microarray gene expression data sets available through public repositories, new possibilities lie in combining multiple existing data sets. In this new context, analysis itself is no longer the problem, but retrieving and consistently integrating all this data before delivering it to the wide variety of existing analysis tools becomes the new bottleneck.ResultsWe present the newly released inSilicoMerging R/Bioconductor package which, together with the earlier released inSilicoDb R/Bioconductor package, allows consistent retrieval, integration and analysis of publicly available microarray gene expression data sets. Inside the inSilicoMerging package a set of five visual and six quantitative validation measures are available as well.ConclusionsBy providing (i) access to uniformly curated and preprocessed data, (ii) a collection of techniques to remove the batch effects between data sets from different sources, and (iii) several validation tools enabling the inspection of the integration process, these packages enable researchers to fully explore the potential of combining gene expression data for downstream analysis. The power of using both packages is demonstrated by programmatically retrieving and integrating gene expression studies from the InSilico DB repository [https://insilicodb.org/app/].
Genome Biology | 2012
Alain Coletta; Colin Molter; Robin Duque; David Steenhoff; Jonatan Taminau; Virginie de Schaetzen; Stijn Meganck; Cosmin Lazar; David Venet; Vincent Detours; Ann Nowé; Hugues Bersini; David Weiss Solís
Genomics datasets are increasingly useful for gaining biomedical insights, with adoption in the clinic underway. However, multiple hurdles related to data management stand in the way of their efficient large-scale utilization. The solution proposed is a web-based data storage hub. Having clear focus, flexibility and adaptability, InSilico DB seamlessly connects genomics dataset repositories to state-of-the-art and free GUI and command-line data analysis tools. The InSilico DB platform is a powerful collaborative environment, with advanced capabilities for biocuration, dataset sharing, and dataset subsetting and combination. InSilico DB is available from https://insilicodb.org.
Bioinformatics | 2011
Jonatan Taminau; David Steenhoff; Alain Coletta; Stijn Meganck; Cosmin Lazar; Virginie de Schaetzen; Robin Duque; Colin Molter; Hugues Bersini; Ann Nowé; David Weiss Solís
Microarray technology has become an integral part of biomedical research and increasing amounts of datasets become available through public repositories. However, re-use of these datasets is severely hindered by unstructured, missing or incorrect biological samples information; as well as the wide variety of preprocessing methods in use. The inSilicoDb R/Bioconductor package is a command-line front-end to the InSilico DB, a web-based database currently containing 86 104 expert-curated human Affymetrix expression profiles compiled from 1937 GEO repository series. The use of this package builds on the Bioconductor projects focus on reproducibility by enabling a clear workflow in which not only analysis, but also the retrieval of verified data is supported.
data integration in the life sciences | 2007
Steve Pettifer; Katy Wolstencroft; Pinar Alper; Teresa K. Attwood; Alain Coletta; Carole A. Goble; Peter Li; Philip McDermott; James Marsh; Tom Oinn; James Sinnott; David Thorne
In silico experiments have hitherto required ad hoc collections of scripts and programs to process and visualise biological data, consuming substantial amounts of time and effort to build, and leading to tools that are difficult to use, are architecturally fragile and scale poorly. With examples of the systems applied to real biological problems, we describe two complimentary software frameworks that address this problem in a principled manner; myGrid/Taverna, a workflow design and enactment environment enabling coherent experiments to be built, and UTOPIA, a flexible visualisation system to aid in examining experimental results.
IEEE/ACM Transactions on Computational Biology and Bioinformatics | 2013
Cosmin Lazar; Jonatan Taminau; Stijn Meganck; David Steenhoff; Alain Coletta; David Weiss Solís; Colin Molter; Robin Duque; Hugues Bersini; Ann Nowé
The potential of microarray gene expression (MAGE) data is only partially explored due to the limited number of samples in individual studies. This limitation can be surmounted by merging or integrating data sets originating from independent MAGE experiments, which are designed to study the same biological problem. However, this process is hindered by batch effects that are study-dependent and result in random data distortion; therefore numerical transformations are needed to render the integration of different data sets accurate and meaningful. Our contribution in this paper is two-fold. First we propose GENESHIFT, a new nonparametric batch effect removal method based on two key elements from statistics: empirical density estimation and the inner product as a distance measure between two probability density functions; second we introduce a new validation index of batch effect removal methods based on the observation that samples from two independent studies drawn from a same population should exhibit similar probability density functions. We evaluated and compared the GENESHIFT method with four other state-of-the-art methods for batch effect removal: Batch-mean centering, empirical Bayes or COMBAT, distance-weighted discrimination, and cross-platform normalization. Several validation indices providing complementary information about the efficiency of batch effect removal methods have been employed in our validation framework. The results show that none of the methods clearly outperforms the others. More than that, most of the methods used for comparison perform very well with respect to some validation indices while performing very poor with respect to others. GENESHIFT exhibits robust performances and its average rank is the highest among the average ranks of all methods used for comparison.
BMC Genomics | 2015
Manuel Corpas; Willy Valdivia-Granda; Nazareth Torres; Bastian Greshake; Alain Coletta; Alexej Knaus; Andrew P. Harrison; Mike Cariaso; Federico Morán; Fiona Nielsen; Daniel Swan; David Weiss Solís; Peter Krawitz; Frank Schacherer; Peter Schols; Huangming Yang; Pascal Borry; Gustavo Glusman; Peter N. Robinson
BackgroundWe describe the pioneering experience of a Spanish family pursuing the goal of understanding their own personal genetic data to the fullest possible extent using Direct to Consumer (DTC) tests. With full informed consent from the Corpas family, all genotype, exome and metagenome data from members of this family, are publicly available under a public domain Creative Commons 0 (CC0) license waiver. All scientists or companies analysing these data (“the Corpasome”) were invited to return results to the family.MethodsWe released 5 genotypes, 4 exomes, 1 metagenome from the Corpas family via a blog and figshare under a public domain license, inviting scientists to join the crowdsourcing efforts to analyse the genomes in return for coauthorship or acknowldgement in derived papers. Resulting analysis data were compiled via social media and direct email.ResultsHere we present the results of our investigations, combining the crowdsourced contributions and our own efforts. Four companies offering annotations for genomic variants were applied to four family exomes: BIOBASE, Ingenuity, Diploid, and GeneTalk. Starting from a common VCF file and after selecting for significant results from company reports, we find no overlap among described annotations. We additionally report on a gut microbiome analysis of a member of the Corpas family.ConclusionsThis study presents an analysis of a diverse set of tools and methods offered by four DTC companies. The striking discordance of the results mirrors previous findings with respect to DTC analysis of SNP chip data, and highlights the difficulties of using DTC data for preventive medical care. To our knowledge, the data and analysis results from our crowdsourced study represent the most comprehensive exome and analysis for a family quartet using solely DTC data generation to date.
bioRxiv | 2013
Manuel Corpas; Mike Cariaso; Alain Coletta; David Weiss; Andrew P. Harrison; Federico Morán; Huanming Yang
Background The availability of open access genomic data is essential for the personal genomics field. Public genomic data allow comparative analyses, testing of new tools and genotype-phenotype association studies. Personal genomics data of unrelated individuals are available in the public domain, notably the Personal Genome Project; however, to date genomics family data and metadata are severely lacking, mainly due to cost, privacy concerns or restricted access to Next Generation Sequencing (NGS) technology. Family data have a lot to offer as they allow the study of heritability, something which is impossible to do just by using unrelated individuals. Findings A whole family from Southern Spain decided to genotype, sequence and analyse their personal genomes making them publicly available under a Creative Commons 0 license (CC0; commonly denominated as public domain). These data include a) five 23andMe SNP chip genotype bed files, b) four raw exomes with their assorted bam files and VCF files, c) a metagenomic raw sequencing data file and d) derived data of likely phenotypes using SNPedia-derived tools. Conclusions To our knowledge this is the first CC0 released set of genomic, phenotypic and metagenomic data for a whole family. This dataset is also unique in that it was obtained through direct-to-consumer genetic tests. Hence any ordinary citizen with enough budget and samples should be able to reproduce this experiment. We envisage this dataset to be a useful resource for a variety of applications in the personal genomics field as a) negative control data for trait association discovery, b) testing data for development of new software and c) sample data for heritability studies. We encourage prospective users to share with us derived results so that they can be added to our existing collection.